MarketBeat Instant News Alerts 2 hours agoOlema Pharmaceuticals (NASDAQ:OLMA) Receives Sell (D-) Rating from Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (d-)" rating on shares of Olema Pharmaceuticals in a report on Saturday.NASDAQ:OLMARead Olema Pharmaceuticals (NASDAQ:OLMA) Receives Sell (D-) Rating from Weiss Ratings2 hours agoOllie's Bargain Outlet's (OLLI) "Buy (B)" Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "buy (b)" rating on shares of Ollie's Bargain Outlet in a report on Saturday.NASDAQ:OLLIRead Ollie's Bargain Outlet's (OLLI) "Buy (B)" Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D-) Rating for OKYO Pharma (NASDAQ:OKYO)MarketBeatWeiss Ratings restated a "sell (d-)" rating on shares of OKYO Pharma in a research note on Saturday.NASDAQ:OKYORead Weiss Ratings Reiterates Sell (D-) Rating for OKYO Pharma (NASDAQ:OKYO)2 hours agoOkta's (OKTA) "Hold (C-)" Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reiterated a "hold (c-)" rating on shares of Okta in a research report on Saturday.NASDAQ:OKTARead Okta's (OKTA) "Hold (C-)" Rating Reiterated at Weiss Ratings2 hours agoOrganigram Global's (OGI) Sell (D) Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d)" rating on shares of Organigram Global in a research report on Saturday.NASDAQ:OGIRead Organigram Global's (OGI) Sell (D) Rating Reiterated at Weiss Ratings2 hours agoOmega Flex (NASDAQ:OFLX) Given "Sell (D+)" Rating at Weiss RatingsMarketBeatWeiss Ratings reissued a "sell (d+)" rating on shares of Omega Flex in a report on Saturday.NASDAQ:OFLXRead Omega Flex (NASDAQ:OFLX) Given "Sell (D+)" Rating at Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock3Nebius Group (NBIS) to Release Earnings on Wednesday4Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why5Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened6Verizon Communications (NYSE:VZ) Stock Price Down 1.1% Following Analyst Downgrade7HC Wainwright Has Positive Outlook of Plug Power Q3 Earnings8HCM II Acquisition (NASDAQ:HOND) Stock Price Down 10.9% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoOrthofix Medical (NASDAQ:OFIX) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:OFIXRead Orthofix Medical (NASDAQ:OFIX) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoOdysight.ai's (ODYS) Sell (E) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ODYSRead Odysight.ai's (ODYS) Sell (E) Rating Reaffirmed at Weiss Ratings2 hours agoOld Dominion Freight Line (NASDAQ:ODFL) Receives Hold (C-) Rating from Weiss RatingsMarketBeatNASDAQ:ODFLRead Old Dominion Freight Line (NASDAQ:ODFL) Receives Hold (C-) Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Hold (C)" Rating for ODDITY Tech (NASDAQ:ODD)MarketBeatNASDAQ:ODDRead Weiss Ratings Reaffirms "Hold (C)" Rating for ODDITY Tech (NASDAQ:ODD)2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Ocular Therapeutix (NASDAQ:OCUL)MarketBeatNASDAQ:OCULRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Ocular Therapeutix (NASDAQ:OCUL)2 hours agoOaktree Specialty Lending's (OCSL) "Hold (C-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:OCSLRead Oaktree Specialty Lending's (OCSL) "Hold (C-)" Rating Reiterated at Weiss Ratings2 hours agoOculis (NASDAQ:OCS) Given Sell (D-) Rating at Weiss RatingsMarketBeatNASDAQ:OCSRead Oculis (NASDAQ:OCS) Given Sell (D-) Rating at Weiss Ratings2 hours agoOcugen (NASDAQ:OCGN) Receives "Sell (E+)" Rating from Weiss RatingsMarketBeatNASDAQ:OCGNRead Ocugen (NASDAQ:OCGN) Receives "Sell (E+)" Rating from Weiss Ratings2 hours agoOceanFirst Financial (NASDAQ:OCFC) Receives "Hold (C)" Rating from Weiss RatingsMarketBeatNASDAQ:OCFCRead OceanFirst Financial (NASDAQ:OCFC) Receives "Hold (C)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Optical Cable (NASDAQ:OCC)MarketBeatNASDAQ:OCCRead Weiss Ratings Reaffirms Sell (D-) Rating for Optical Cable (NASDAQ:OCC)2 hours agoOrange County Bancorp (NASDAQ:OBT) Given Hold (C+) Rating at Weiss RatingsMarketBeatNASDAQ:OBTRead Orange County Bancorp (NASDAQ:OBT) Given Hold (C+) Rating at Weiss Ratings2 hours agoOrchestra BioMed (NASDAQ:OBIO) Earns "Sell (E+)" Rating from Weiss RatingsMarketBeatNASDAQ:OBIORead Orchestra BioMed (NASDAQ:OBIO) Earns "Sell (E+)" Rating from Weiss Ratings2 hours agoOak Woods Acquisition's (OAKU) Sell (D+) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:OAKURead Oak Woods Acquisition's (OAKU) Sell (D+) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D-) Rating for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)MarketBeatNASDAQ:OACCRead Weiss Ratings Reiterates Sell (D-) Rating for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)2 hours agoNyxoah's (NYXH) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:NYXHRead Nyxoah's (NYXH) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Hold (C)" Rating for NXP Semiconductors (NASDAQ:NXPI)MarketBeatNASDAQ:NXPIRead Weiss Ratings Reiterates "Hold (C)" Rating for NXP Semiconductors (NASDAQ:NXPI)2 hours agoNWPX Infrastructure's (NWPX) Hold (C+) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:NWPXRead NWPX Infrastructure's (NWPX) Hold (C+) Rating Reiterated at Weiss Ratings2 hours agoNOVONIX's (NVX) Sell (E+) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:NVXRead NOVONIX's (NVX) Sell (E+) Rating Reiterated at Weiss Ratings2 hours agoNVE's (NVEC) "Hold (C)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:NVECRead NVE's (NVEC) "Hold (C)" Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Buy (B)" Rating for NVIDIA (NASDAQ:NVDA)MarketBeatNASDAQ:NVDARead Weiss Ratings Reiterates "Buy (B)" Rating for NVIDIA (NASDAQ:NVDA)2 hours agoNuvectis Pharma's (NVCT) "Sell (E+)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:NVCTRead Nuvectis Pharma's (NVCT) "Sell (E+)" Rating Reaffirmed at Weiss Ratings2 hours agoNovoCure (NASDAQ:NVCR) Receives "Sell (E+)" Rating from Weiss RatingsMarketBeatNASDAQ:NVCRRead NovoCure (NASDAQ:NVCR) Receives "Sell (E+)" Rating from Weiss Ratings2 hours agoNuvalent (NASDAQ:NUVL) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:NUVLRead Nuvalent (NASDAQ:NUVL) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoNutex Health (NASDAQ:NUTX) Given "Hold (C-)" Rating at Weiss RatingsMarketBeatNASDAQ:NUTXRead Nutex Health (NASDAQ:NUTX) Given "Hold (C-)" Rating at Weiss Ratings Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025Move $1,000 into this stock before Nov 6From Altimetry (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 2025INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffFrom Traders Agency (Ad)2 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
